Where does Northwest Biotherapeutics, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Northwest Biotherapeutics, Inc. ranks #49,177 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Northwest Biotherapeutics, Inc. hold?

Northwest Biotherapeutics, Inc. holds 5 US utility patents granted between 2015 and 2023, spanning 5 technology areas.

What is Northwest Biotherapeutics, Inc.'s Innovation Score?

Northwest Biotherapeutics, Inc. has an Innovation Score of 26.9 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Northwest Biotherapeutics, Inc.'s patent grant rate increasing or decreasing?

Northwest Biotherapeutics, Inc.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Northwest Biotherapeutics, Inc.'s patents?

Northwest Biotherapeutics, Inc.'s patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Northwest Biotherapeutics, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Northwest Biotherapeutics, Inc.

Q: What technology areas does Northwest Biotherapeutics, Inc. focus on?

Northwest Biotherapeutics, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 4 patents, ranking #2,122 of 4,144 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Northwest ranks #49,177 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#49,177
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (26.9/100): 15.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49177 · US Corporation #49,177 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,177/49,997
PHOTO-FINISH North China…
CPC-NARROW C12N · 5 areas
INNOV-THIN 26.9/100
CLAIMS-RICH 15.8 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: North China Electric Power University (Baoding) (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Northwest’s 26.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (23%) Velocity 3.3 pts (12%) Breadth 7.9 pts (29%) Claim depth 9.5 pts (35%)

Qualcomm Incorporated · highest

85
Northwest Biotherape… · this assignee

27
3D Lighting… · lowest

7

What this shows Northwest's Innovation Score is 26.9/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Northwest?

Each dot is one of Northwest’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Northwest’s own 15.8 claims/patent is ABOVE the 7.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Northwest vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Northwest's grants concentrate

Northwest Biotherapeutics, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). By volume, Northwest sits between North China Electric Power University (Baoding) and Norwegian University of Life Sciences (NMBU).

Northwest's three-year grant acceleration

Northwest Biotherapeutics, Inc. shows 1 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

North China Elect…

5
North China Unive…

5
North Star Techno…

5
Northern Power Sy…

5
Northwest Pipe

5
Northwest River S…

5
Nortic Holdings

5
Norwegian Univers…

5
Northwest Biother… ◀

5

What this shows Northwest holds 5 patents at rank #49,213, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Northwest

By rank, the assignees closest to #49,213 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Northwest's primary technology class.

Northwest's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Northwest Biotherapeutics, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	20.0%
2017	1	20.0%
2020	1	20.0%
2021	1	20.0%
2023	1	20.0%

Which technologies does Northwest Biotherapeutics, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C07K - Peptides 1

A01K - Animal HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; Rearing OR Breeding Animals, NOT Otherwise Provided FOR; NEW Breeds OF Animals 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Northwest Biotherapeutics, Inc.'s patent record in context - here's where to go next.

Northwest Biotherapeutics, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 80% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #49,177 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Northwest Biotherapeutics, Inc. against North China Electric Power University (Baoding), an assignee filing at a similar volume. Compare portfolios
Innovation Score of 26.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.